Results

201 - 210 of 402 results for ‘guidelines’.

  • National Infection Prevention and Control Leadership Group

    https://www.tewhatuora.govt.nz/corporate-information/about-us/expert-groups/national-infection-prevention-and-control-leadership-group

    The National Infection Prevention and Control Leadership Group develops guidelines on the best ways to reduce infections within the health secto

  • HISO 10071:2019 Cardiovascular Disease Risk Assessment Data Standard

    https://www.tewhatuora.govt.nz/publications/hiso-100712019-cardiovascular-disease-risk-assessment-data-standard

    Summary In 2003, the Health Research Council of New Zealand (HRC) funded the PREDICT cohort study. The study’s purpose was to develop new cardiovascular disease (CVD) risk prediction models for the New Zealand population, while simultaneously supporting the implementation of CVD and diabetes guidelines through computerised decision support (Wells et al 2015). As of December 2017, general practitioners (GPs) and nurses had conducted heart and diabetes checks for over 500,000 patients using the PREDICT web-based platform. With national ethics approval and permission from

  • New Zealand Health Facility Design Guidance Note

    https://www.tewhatuora.govt.nz/publications/health-facility-design-guidance-note

    This is a revised version of the current Facility Design Guidance Note (DGN). The new DGN is simpler and is designed to be read as a supplement to the Australasian Health Facility Guidelines  (AusHFG). It has fewer duplications from the AusHFG, and greater focus on NZ specific design guidance. The DGN provides design principles specific to Aotearoa New Zealand that are not included in the AusHFG. It will support project design teams to implement the AusHFG by ensuring Aotearoa specific requirements are articulated and can be addressed in the design process. This version of the DGN

  • Legionellosis

    https://www.tewhatuora.govt.nz/for-health-professionals/clinical-guidance/communicable-disease-control-manual/legionellosis

    in New Zealand can be found in the Ministry of Health publication  The Prevention of Legionellosis in New Zealand: Guidelines for the control of legionella bacteria  (Ministry of Health 2011 ... Zealand: Guidelines for the control of legionella bacteria  (Ministry of Health 2011) for detailed information on investigation of cases. The medical officer of health is responsible for coordinating ... Reference Laboratory at ESR. For further information on disinfection, refer to  The Prevention of Legionellosis in New Zealand: Guidelines for the control of legionella bacteria  (Ministry

  • Appendix 1: Disinfection

    https://www.tewhatuora.govt.nz/for-health-professionals/clinical-guidance/communicable-disease-control-manual/appendix-1-disinfection

    process on how to use them and manufacturer’s recommendations are followed References and further information Ministry of Health. 2009.   Guidelines for the Management

  • Appendix 1: Ultrasound scan codes and indications

    https://www.tewhatuora.govt.nz/for-health-professionals/health-workforce-development/maternity/new-zealand-obstetric-ultrasound-guidelines-online/appendices/appendix-1-ultrasound-scan-codes-and-indications

    Appendix 1 for the New Zealand Obstetric Ultrasound Guidelines.

  • Appendix 3: Ectopic pregnancy location

    https://www.tewhatuora.govt.nz/for-health-professionals/health-workforce-development/maternity/new-zealand-obstetric-ultrasound-guidelines-online/appendices/appendix-3-ectopic-pregnancy-location

    Appendix 3 for the New Zealand Obstetric Ultrasound Guidelines.

  • Appendix 8: Anatomic locations of ventricular septal defects

    https://www.tewhatuora.govt.nz/for-health-professionals/health-workforce-development/maternity/new-zealand-obstetric-ultrasound-guidelines-online/appendices/appendix-8-anatomic-locations-of-ventricular-septal-defects

    Appendix 8 for the New Zealand Obstetric Ultrasound Guidelines.

  • Anaphylaxis response/management

    https://www.tewhatuora.govt.nz/for-health-professionals/clinical-guidance/immunisation-handbook/anaphylaxis-responsemanagement

    10 kg or if weight is not known, use the following guidelines: Age Dose under 2 years 0.1 mL 2–4 years 0.2 m

  • About antenatal screening for Down syndrome and other conditions

    https://www.tewhatuora.govt.nz/health-services-and-programmes/antenatal-screening-for-down-syndrome-and-other-conditions/about-antenatal-screening-for-down-syndrome-and-other-conditions

    at the time. The improvements were introduced in 2010 and included incorporating maternal serum screening with ultrasound and providing practitioner guidelines and consumer resources. Since 2010, further